Loading clinical trials...
Loading clinical trials...
This study will test the effectiveness and the safety of giving two antifungal agents (voriconazole and anidulafungin) together to treat invasive aspergillosis in patients who are unable to tolerate p...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Pfizer
NCT03748069 · Influenza With Pneumonia, Invasive Pulmonary Aspergillosis
NCT06244979 · Pulmonary Aspergillosis, Chronic Pulmonary Aspergillosis, and more
NCT06537726 · Leukemia, Leukemia, Myeloid, and more
NCT03717623 · Posaconazole, Pharmacokinetics, and more
NCT06440915 · Aspergillosis Invasive, Mucormycosis
Pfizer Investigational Site
Atlanta, Georgia
Pfizer Investigational Site
Detroit, Michigan
Pfizer Investigational Site
Fort Worth, Texas
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions